That's acceptable, 3X is fair bellwether. Right now, it is trading as a pre-revenue company might with prospects but no paychecks. It's expected to have volatility and slow bleeding I to a binary event. I won't prognosticate one way or the other, I am an options trader and trade for high percentage, high profit situations. My first impression with a gun to my head, they look strong going into the FDA decision, and I would likely profit 1000%+ in that situation as opposed to ~500% on a denial (assuming drop to $2 area). But as I said, I don't buy shares in my trading account, only my core, and my core holds 4 Biotechs fairly heavy. SRPT, LLY, PFE and GILD. GL to you